Single-dose inhaled laninamivir: Registered in Japan and its potential role in control of influenza epidemics

Influenza and other Respiratory Viruses

Volumn 7, Issue 1, 2013, Pages 1-3

  Sunagawa, Satoko ^a   Higa, Futoshi ^a   Cash, Haley L ^a   Tateyama, Masao ^a   Uno, Tsukasa ^a   Fujita, Jiro ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Anti influenza drugs; Influenza; Pandemic

Indexed keywords

LANINAMIVIR OCTANOATE; OSELTAMIVIR; PERAMIVIR; ZANAMIVIR;

2009 H1N1 INFLUENZA; AVIAN INFLUENZA; DRUG MECHANISM; EPIDEMIC; HUMAN; INFECTION CONTROL; INFLUENZA; JAPAN; LETTER; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ADMINISTRATION, INHALATION; ANTIVIRAL AGENTS; EPIDEMICS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; JAPAN; NEURAMINIDASE; ZANAMIVIR;

EID: 84871361554     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/j.1750-2659.2012.00351.x     Document Type: Letter

References (6)

1. Moscona A. Neuraminidase Inhibitors for Influenza. N Engl J Med 2005; 353:1363-1373.
2. Jain S, Kamimoto L, Bramley AM et al. 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009; 361:135-144.
3. Kohno S, Kida H, Mizuguchi M, Shimada J, S-021812 Clinical Study Group. Efficacy and safety of intravenous peramivir for treatment of seasonal influenza virus infection. Antimicrob Agents Chemother 2010; 54:4568-4574.
4. Hernandez JE, Adiga R, Armstrong R et al. Clinical experience in adults and children treated with intravenous Peramivir for 2009 influenza A (H1N1) Under an emergency IND program in the United States. Clin Infect Dis 2011; 52:695-706.
5. Watanabe A, Chang SC, Kim MJ, Chu DW, Ohashi Y, MARVEL Study Group. Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: A double-blind, randomized, noninferiority clinical trial. Clin Infect Dis 2010; 51:1167-1175.
6. Sugaya N, Ohashi Y. Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection. Antimicrob Agents Chemother 2010; 54:2575-2582.